TNDM · Tandem Diabetes Care Inc
$17.92
-1.67 (-8.52%)
At close · Aug 6
Earnings today
Market Cap
$1.34B
Shares
68.53M
Tandem Diabetes Care Inc Earnings Call Transcripts
Every quarterly earnings call for Tandem Diabetes Care Inc (TNDM) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲13.9%
$204.55M
−$48.97M
'22 Q3
22-11-02
▲5%
$220.50M
−$15.85M
'22 Q4
23-01-10
▼3.7%
$169.38M
−$123.87M
'23 Q1
23-05-03
▼2.2%
$195.92M
−$35.77M
'23 Q2
23-08-03
▼9.3%
$185.62M
−$32.96M
'23 Q3
23-11-01
▼10.8%
$196.80M
−$30.00M
'23 Q4
24-02-21
▲13.2%
$191.67M
−$42.72M
'24 Q1
24-05-02
▲13.3%
$221.91M
−$30.81M
'24 Q2
24-08-01
▲31.4%
$243.97M
−$23.25M
'24 Q3
24-11-06
▲43.6%
$282.65M
$755,000
'24 Q4
25-02-26
▲22.3%
$234.42M
−$130.56M
'25 Q1
25-04-30
▲8.5%
$240.68M
−$52.40M
'25 Q2
25-08-06
▲2.2%
$249.25M
−$21.16M
'25 Q3
25-11-06
▲2.7%
$290.38M
−$589,000
'25 Q4
26-02-19
LATEST
▲5.5%
$247.22M
−$20.39M
'26 Q1
26-05-07
Conference
Investor event
2026-08-11
Canaccord Genuity’s 46th Annual Growth Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Tandem Diabetes Care Q2 2026 Earnings
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Tandem Diabetes Care Inc Q1 FY2026 Earnings Call
Confident tone
Pharmacy/PayGo transition
New product launches and pipeline
International expansion / direct operations
Revenue
$247.22M
▲ 5.5% YoY Diluted EPS
$-0.30
Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Tandem Diabetes Care Inc Q4 FY2025 Earnings Call
Revenue
$290.38M
▲ 2.7% YoY Diluted EPS
$-0.01
▼ 200% YoY Gross margin
57.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Tandem Diabetes Care Inc Q3 FY2025 Earnings Call
Confident tone
Pharmacy reimbursement strategy
Profitability and margin improvement
Product innovation and pipeline
Revenue
$249.25M
▲ 2.2% YoY Diluted EPS
$-0.31
Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Tandem Diabetes Care Inc Q2 FY2025 Earnings Call
Positive tone
Tandem Mobi product momentum
Type 2 diabetes expansion
U.S. commercial performance and pump shipments
Revenue
$240.68M
▲ 8.5% YoY Diluted EPS
$-0.78
Gross margin
52.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
Tandem Diabetes Care Inc Q1 FY2025 Earnings Call
Confident tone
Gross Margin Expansion Path
Pharmacy Channel Access
International Growth and Direct Sales Transition
Revenue
$234.42M
▲ 22.3% YoY Diluted EPS
$-1.97
Gross margin
50.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Tandem Diabetes Care Inc Q4 FY2024 Earnings Call
Confident tone
Tandem Mobi pump platform
Type 2 diabetes label expansion
Control-IQ+ algorithm launch
Revenue
$282.65M
▲ 43.6% YoY Diluted EPS
$0.01
Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Tandem Diabetes Care Inc Q3 FY2024 Earnings Call
Confident tone
Type 2 diabetes market opportunity
Tandem Mobi launch and adoption
Renewals momentum
Revenue
$243.97M
▲ 31.4% YoY Diluted EPS
$-0.35
Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Tandem Diabetes Care Inc Q2 FY2024 Earnings Call
Confident tone
Tandem Mobi launch
Control-IQ algorithm
New sensor integrations / CGM partnerships
Revenue
$221.91M
▲ 13.3% YoY Diluted EPS
$-0.47
Gross margin
50.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Tandem Diabetes Care Inc Q1 FY2024 Earnings Call
Confident tone
Mobi product launch
Guidance philosophy and conservatism
Pharmacy channel opportunity
Revenue
$191.67M
▲ 13.2% YoY Diluted EPS
$-0.65
Gross margin
49.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Tandem Diabetes Care Inc Q4 FY2023 Earnings Call
Confident tone
Tandem Mobi launch
Renewals and customer base growth
International expansion and OUS challenges
Revenue
$196.80M
▼ 10.8% YoY Diluted EPS
$-0.46
Gross margin
47.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Tandem Diabetes Care Inc Q3 FY2023 Earnings Call
Revenue
$185.62M
▼ 9.3% YoY Diluted EPS
$-0.51
Gross margin
48.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Tandem Diabetes Care Inc Q2 FY2023 Earnings Call
Revenue
$195.92M
▼ 2.2% YoY Diluted EPS
$-0.55
Gross margin
51.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Tandem Diabetes Care Inc Q1 FY2023 Earnings Call
Revenue
$169.38M
▼ 3.7% YoY Diluted EPS
$-1.92
Gross margin
48.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-10
Tandem Diabetes Care Inc Q4 FY2022 Earnings Call
Revenue
$220.50M
▲ 5% YoY Diluted EPS
$-0.25
▼ 256.2% YoY Gross margin
52.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Tandem Diabetes Care Inc Q3 FY2022 Earnings Call
Revenue
$204.55M
▲ 13.9% YoY Diluted EPS
$-0.76
▼ 944.4% YoY Gross margin
51.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Tandem Diabetes Care Inc Q2 FY2022 Earnings Call
Revenue
$200.26M
▲ 16.3% YoY Diluted EPS
$-0.24
▼ 500% YoY Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Tandem Diabetes Care Inc Q1 FY2022 Earnings Call
Revenue
$175.91M
▲ 24.7% YoY Diluted EPS
$-0.23
Gross margin
51.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Tandem Diabetes Care Inc Q4 FY2021 Earnings Call
Revenue
$210.00M
▲ 24.9% YoY Diluted EPS
$0.16
▼ 27.3% YoY Gross margin
54.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Tandem Diabetes Care Inc Q3 FY2021 Earnings Call
Revenue
$179.63M
▲ 45.3% YoY Diluted EPS
$0.09
Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Tandem Diabetes Care Inc Q2 FY2021 Earnings Call
Revenue
$172.14M
▲ 57.6% YoY Diluted EPS
$0.06
Gross margin
53.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Tandem Diabetes Care Inc Q1 FY2021 Earnings Call
Revenue
$141.04M
▲ 44% YoY Diluted EPS
$-0.08
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Tandem Diabetes Care Inc Q4 FY2020 Earnings Call
Revenue
$168.06M
▲ 55% YoY Diluted EPS
$0.22
▲ 450% YoY Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Tandem Diabetes Care Inc Q3 FY2020 Earnings Call
Revenue
$123.60M
▲ 30.6% YoY Diluted EPS
$-0.15
Gross margin
52.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Tandem Diabetes Care Inc Q2 FY2020 Earnings Call
Revenue
$109.24M
▲ 17.1% YoY Diluted EPS
$-0.45
Gross margin
49.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Tandem Diabetes Care Inc Q1 FY2020 Earnings Call
Revenue
$97.93M
▲ 48.4% YoY Diluted EPS
$-0.25
Gross margin
51.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Tandem Diabetes Care Inc Q4 FY2019 Earnings Call
Revenue
$108.40M
▲ 42.3% YoY Diluted EPS
$0.04
▲ 100% YoY Gross margin
55.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 earnings calls
Key facts
CIK
1438133
CUSIP
875372203
13F (30d)
73 filings
73 filers
Visit website
Investor relations